How is chronic immune thrombocytopenic purpura (ITP) platelet disorder in adults treated?

Updated: Aug 05, 2017
  • Author: Perumal Thiagarajan, MD; Chief Editor: Srikanth Nagalla, MBBS, MS, FACP  more...
  • Print


No consensus has been reached regarding when to start steroid therapy for chronic immune thrombocytopenia (ITP) in adults and how long to treat it. [2, 7, 20, 21] The American Society of Hematology 2011 guidelines recommend treating patients with a platelet count <30,000/µl. Patients with bleeding manifestations may need to be treated to keep platelet counts >50,000/µl or even higher depending on the severity and location of the bleed.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!